Objectives
- To review the latest Olumiant real world evidence and demonstrate the
consistency of results between this and the clinical evidence.
- To discuss why Olumiant should be used earlier in the treatment pathway
and is the perfect molecule to implement a treat to target approach.
- To agree that Olumiant should be a good contender for JAKI of choice.
This Course For :
Physician
( Rheumatology )
Resident / Fellow
( Rheumatology )
Speaker
Prof. Peter C Taylor
Oxford, UK
Prof. Mart van de Laar
Twente, The Netherlands
Professor Rieke Alten
Berlin, Germany
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
21 Feb 2024 To 21 Feb 2024 -
09:30 PM To 10:30 PM 
Certificate Available 
Online Click Here
- 17
Add to Calendar
02/21/2024 09:30 PM
02/21/2024 10:30 PM
Asia/ Riyadh
Re-run eP2P Should Olumiant® be the JAKi of choice in rheumatoid arthritis? A review of the evidence
Re-run eP2P Should Olumiant® be the JAKi of choice in rheumatoid arthritis? A review of the evidence
https://medicalacademy.org/portal/event/view/2132
